Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 6 | 2025 | 364 | 1.980 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2024 | 22 | 0.840 |
Why?
|
| Coronary Angiography | 1 | 2025 | 232 | 0.830 |
Why?
|
| Computed Tomography Angiography | 1 | 2025 | 162 | 0.810 |
Why?
|
| Aortic Coarctation | 2 | 2023 | 31 | 0.800 |
Why?
|
| Vasodilator Agents | 1 | 2023 | 132 | 0.760 |
Why?
|
| Echocardiography | 4 | 2024 | 748 | 0.740 |
Why?
|
| Anesthesia, General | 1 | 2023 | 127 | 0.730 |
Why?
|
| Tetralogy of Fallot | 2 | 2020 | 46 | 0.720 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2024 | 3450 | 0.690 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2021 | 67 | 0.670 |
Why?
|
| Contrast Media | 1 | 2025 | 986 | 0.660 |
Why?
|
| Education, Distance | 1 | 2020 | 25 | 0.640 |
Why?
|
| Pulmonary Atresia | 1 | 2020 | 12 | 0.640 |
Why?
|
| Adenosine | 1 | 2023 | 274 | 0.630 |
Why?
|
| Cardiology | 1 | 2020 | 120 | 0.600 |
Why?
|
| Chloral Hydrate | 1 | 2019 | 3 | 0.590 |
Why?
|
| Pentobarbital | 1 | 2019 | 16 | 0.590 |
Why?
|
| Angioplasty, Balloon | 1 | 2019 | 90 | 0.580 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 144 | 0.580 |
Why?
|
| Infant | 6 | 2025 | 3156 | 0.580 |
Why?
|
| Conscious Sedation | 1 | 2019 | 77 | 0.560 |
Why?
|
| Child, Preschool | 7 | 2025 | 3781 | 0.540 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 137 | 0.530 |
Why?
|
| Child | 10 | 2025 | 7273 | 0.520 |
Why?
|
| Systemic Inflammatory Response Syndrome | 3 | 2021 | 59 | 0.510 |
Why?
|
| Predictive Value of Tests | 4 | 2025 | 1703 | 0.500 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2020 | 505 | 0.500 |
Why?
|
| Stents | 1 | 2019 | 406 | 0.490 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 425 | 0.490 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2015 | 145 | 0.480 |
Why?
|
| Pediatrics | 1 | 2020 | 378 | 0.480 |
Why?
|
| Heart Failure | 1 | 2024 | 1376 | 0.420 |
Why?
|
| Pulmonary Artery | 2 | 2013 | 333 | 0.420 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2013 | 42 | 0.390 |
Why?
|
| Infant, Newborn | 3 | 2025 | 2427 | 0.380 |
Why?
|
| Heart Bypass, Right | 1 | 2010 | 12 | 0.320 |
Why?
|
| Fontan Procedure | 1 | 2010 | 57 | 0.310 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2021 | 258 | 0.290 |
Why?
|
| Retrospective Studies | 9 | 2023 | 10128 | 0.280 |
Why?
|
| Humans | 23 | 2025 | 93132 | 0.280 |
Why?
|
| Age Factors | 2 | 2025 | 1898 | 0.280 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 752 | 0.260 |
Why?
|
| Administration, Intravenous | 1 | 2025 | 63 | 0.230 |
Why?
|
| Radiation Exposure | 1 | 2025 | 25 | 0.230 |
Why?
|
| Cardiac Output, High | 1 | 2024 | 3 | 0.220 |
Why?
|
| Radiation Dosage | 1 | 2025 | 224 | 0.210 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2024 | 87 | 0.210 |
Why?
|
| Female | 14 | 2024 | 48542 | 0.200 |
Why?
|
| Endocarditis | 1 | 2022 | 24 | 0.190 |
Why?
|
| Male | 12 | 2024 | 44355 | 0.180 |
Why?
|
| Adolescent | 6 | 2023 | 9550 | 0.180 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 25 | 0.170 |
Why?
|
| Coronary Aneurysm | 1 | 2021 | 15 | 0.170 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2021 | 9 | 0.170 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 12 | 0.160 |
Why?
|
| Azithromycin | 1 | 2020 | 16 | 0.160 |
Why?
|
| Long QT Syndrome | 1 | 2020 | 35 | 0.160 |
Why?
|
| Collateral Circulation | 1 | 2020 | 36 | 0.160 |
Why?
|
| Needs Assessment | 1 | 2020 | 167 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2025 | 2434 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2020 | 222 | 0.140 |
Why?
|
| Risk Factors | 3 | 2025 | 5900 | 0.140 |
Why?
|
| Thrombosis | 1 | 2021 | 308 | 0.140 |
Why?
|
| Electrocardiography | 1 | 2020 | 496 | 0.130 |
Why?
|
| Young Adult | 6 | 2024 | 6922 | 0.120 |
Why?
|
| Gadolinium | 1 | 2017 | 95 | 0.120 |
Why?
|
| Sarcoidosis | 1 | 2017 | 94 | 0.120 |
Why?
|
| Curriculum | 1 | 2020 | 590 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2021 | 762 | 0.110 |
Why?
|
| Computer Systems | 1 | 2015 | 63 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 338 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 333 | 0.110 |
Why?
|
| Aorta, Thoracic | 1 | 2015 | 148 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 873 | 0.100 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2013 | 13 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 300 | 0.100 |
Why?
|
| Pulmonary Valve | 1 | 2013 | 34 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 2562 | 0.100 |
Why?
|
| India | 2 | 2011 | 141 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2787 | 0.090 |
Why?
|
| Exercise | 1 | 2015 | 353 | 0.090 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2013 | 151 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 186 | 0.090 |
Why?
|
| Chest Tubes | 1 | 2010 | 21 | 0.080 |
Why?
|
| Adult | 7 | 2024 | 27849 | 0.080 |
Why?
|
| Developing Countries | 1 | 2011 | 91 | 0.080 |
Why?
|
| Pleural Effusion | 1 | 2010 | 42 | 0.080 |
Why?
|
| Exercise Tolerance | 1 | 2010 | 63 | 0.080 |
Why?
|
| Warfarin | 1 | 2010 | 106 | 0.070 |
Why?
|
| Drainage | 1 | 2010 | 170 | 0.070 |
Why?
|
| Aspirin | 1 | 2010 | 164 | 0.070 |
Why?
|
| Algorithms | 1 | 2017 | 1948 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2010 | 177 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 753 | 0.070 |
Why?
|
| Ventricular Function, Left | 2 | 2021 | 517 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2010 | 455 | 0.060 |
Why?
|
| Prognosis | 2 | 2024 | 3890 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2010 | 887 | 0.060 |
Why?
|
| Oxygen | 1 | 2010 | 749 | 0.060 |
Why?
|
| Time Factors | 2 | 2011 | 5380 | 0.050 |
Why?
|
| Middle Aged | 4 | 2024 | 27535 | 0.050 |
Why?
|
| Aorta | 1 | 2023 | 273 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2022 | 263 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2023 | 250 | 0.040 |
Why?
|
| Cardiotoxicity | 1 | 2021 | 13 | 0.040 |
Why?
|
| Myocarditis | 1 | 2021 | 59 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2021 | 52 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2011 | 9070 | 0.040 |
Why?
|
| New York City | 1 | 2020 | 69 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 20395 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 78 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2021 | 175 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2020 | 85 | 0.040 |
Why?
|
| Heart | 1 | 2021 | 522 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1160 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 283 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 1519 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 3128 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1697 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1172 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 753 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 750 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 2301 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 354 | 0.020 |
Why?
|
| Reoperation | 1 | 2011 | 696 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 418 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 442 | 0.020 |
Why?
|
| Length of Stay | 1 | 2011 | 820 | 0.020 |
Why?
|